Monika Hollander
Overview
Explore the profile of Monika Hollander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
2456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Canto E, Theunisse S, Bots M, Rutten F, Biermans M, Onland-Moret N, et al.
BJGP Open
. 2025 Feb;
PMID: 39978826
Background: Pharmacological prescription guidelines for hypertension lack differentiation between the sexes, despite reported sex differences in prevalence, awareness, pathophysiology and pharmacological response. Aim: We aimed to assess prescription patterns of...
2.
Schroevers J, Hoevenaar-Blom M, Busschers W, Hollander M, van Gool W, Richard E, et al.
Lancet Reg Health Eur
. 2024 Dec;
47:101132.
PMID: 39633892
[This corrects the article DOI: 10.1016/j.lanepe.2024.100927.].
3.
Vermeer C, Hollander M, Stolk A, Groenewegen A, Geersing G, Geersing G, et al.
BJGP Open
. 2024 Sep;
PMID: 39231593
Background: Natriuretic peptides (NPs) are released by increased ventricular wall stress, most often caused by heart failure (HF). NP level measurement helps select patients clinically suspected of HF who need...
4.
Smits G, Bots M, Hollander M, van Doorn S
BJGP Open
. 2024 Aug;
PMID: 39197878
Background: Treatment targets for cardiovascular risk management (CVRM) make no distinction between women and men. Aim: To explore sex differences in achieving treatment targets in patients who participated in a...
5.
Vermeer C, Groenewegen A, Hollander M, Schuring J, Looijmans-van den Akker I, Oostindjer A, et al.
BMC Prim Care
. 2024 Jun;
25(1):216.
PMID: 38877394
Background: General practitioners (GPs) specialized in cardiovascular disease (GPSI-CVD) may suspect heart failure (HF) more easily than GPs not specialized in CVD. We assessed whether GPSI-CVD consider investigations aimed at...
6.
Schroevers J, Hoevenaar-Blom M, Busschers W, Hollander M, van Gool W, Richard E, et al.
Lancet Reg Health Eur
. 2024 May;
42:100927.
PMID: 38800111
Background: Hypertension is a modifiable risk factor for dementia affecting over 70% of individuals older than 60. Lowering dementia risk through preferential treatment with antihypertensive medication (AHM) classes that are...
7.
Pan K, van Tuijl L, Basten M, Rijnhart J, de Graeff A, Dekker J, et al.
Psychol Med
. 2024 Apr;
54(10):2744-2757.
PMID: 38680088
Background: Although behavioral mechanisms in the association among depression, anxiety, and cancer are plausible, few studies have empirically studied mediation by health behaviors. We aimed to examine the mediating role...
8.
Kiss P, Uijl A, de Boer A, Duk T, Grobbee D, Hollander M, et al.
Heart
. 2024 Apr;
110(15):981-987.
PMID: 38580433
Background: Current guidelines for the prevention and management of cardiovascular diseases (CVD) provide similar recommendations for the use of statins in both women and men. In this study, we assessed...
9.
Smits G, Bots M, Hollander M, Wit A, van Doorn S
BJGP Open
. 2024 Mar;
8(3).
PMID: 38479757
Background: Despite programmatic protocolised care and structured support, considerable variation is observed in completeness of registration and achieving targets of cardiovascular risk management (CVRM) between individual GPs in the Netherlands....
10.
Smits G, van Doorn S, Bots M, Hollander M
BMC Prim Care
. 2024 Feb;
25(1):55.
PMID: 38342918
Background: Since 2010, an increasing number of patients have participated in a nurse-led integrated cardiovascular risk management programme in the Netherlands. Because it is important to understand which patients discontinue...